Visit other SMART + STRONG sites:
AIDSMEDS • REAL HEALTH • TU SALUD
Subscribe to:
• POZ magazine
• E-newsletters
POZ Personals
Sign In / Join		 Username:
 Password:

Back to home » News » August 2006

Web Exclusives

Run This Town

A Voice Against HIV, Malaria and TB

Therapeutic Vaccines: Steady Wins the Race

» More
What You're Talking About
House of Numbers, An AIDS Documentary (blog) (104)

Help Develop a National AIDS Strategy (46)

How Stigma Kills (21)

Obama Lifts HIV Travel Ban (16)

Positive Man Charged Under Anti-Terrorism Laws in Michigan Assault Case (8)
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV
10 Years Ago In POZ



How to End the Epidemic

Blame It on Your Hormones

Dr. Leather Meets Mr. Right

Don't Ask, Don't Tell

» Full Issue

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrsswidgetprint

August 21, 2006

GSK Has a Change of HAART in India

August 21, 2006—GlaxoSmithKline dropped its application today to patent the HIV drug Combivir in India. Local activists had opposed granting such a patent on the grounds that it would raise prices and put local generics producers out of business. But GSK said its decision was an internal matter, not related to the protests. 

emailrsswidgetprint


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    JaieNewGen
    Memphis
    Tennessee


    whilboy
    Los Angeles
    California


    leezaa
    white plains
    New York


    rafaelv
    brooklyn
    New York
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do young people see the HIV/AIDS epidemic as a serious threat?
Yes
No
Survey
It's A Girl Thing

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy